Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd Board/Management Information 2021

Jun 1, 2021

59255_rns_2021-06-01_c4758e8b-cc34-4af3-bcf2-a49d445b940c.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [100 x 31] intentionally omitted <==

Date: 01[st] June, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|

Sub: Resignation of Mr. Dilip Dandekar, Non‐Executive Director.

Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir/Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015), we wish to inform you that Mr. Dilip Dandekar, Non‐Executive Director has resigned from the Company’s directorship with effect from June 1, 2021 on account of personal reasons.

Kindly take the above on record.

Thanking you, For Camlin Fine Sciences Limited Mandar Godbole Company Secretary & General Manager ‐ Legal

==> picture [426 x 57] intentionally omitted <==